Pages that link to "Q37653353"
Jump to navigation
Jump to search
The following pages link to Reversible or irreversible remodeling in pulmonary arterial hypertension (Q37653353):
Displaying 50 items.
- Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View (Q26749283) (← links)
- Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension (Q27010531) (← links)
- Sex differences in the pulmonary circulation: implications for pulmonary hypertension (Q33568826) (← links)
- Recapitulation of developing artery muscularization in pulmonary hypertension (Q33587457) (← links)
- PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension (Q33805920) (← links)
- A Case Series of Young Patients with Completely Reversed Severe Pulmonary Hypertension (Q33832243) (← links)
- Egr-1 expression during neointimal development in flow-associated pulmonary hypertension. (Q34021089) (← links)
- CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats (Q35108148) (← links)
- Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth Muscle (Q35698710) (← links)
- Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension (Q35800881) (← links)
- Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension (Q35825326) (← links)
- miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. (Q35850316) (← links)
- Oxidant signaling for interleukin-13 gene expression in lung smooth muscle cells (Q35926109) (← links)
- Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation (Q36494609) (← links)
- Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery (Q36695298) (← links)
- BIX-01294 treatment blocks cell proliferation, migration and contractility in ovine foetal pulmonary arterial smooth muscle cells (Q36831427) (← links)
- Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism (Q36929766) (← links)
- IL-22 activates oxidant signaling in pulmonary vascular smooth muscle cells (Q37281476) (← links)
- MicroRNAs in pulmonary arterial remodeling (Q37308092) (← links)
- Smooth muscle contractile diversity in the control of regional circulations (Q37575852) (← links)
- BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia (Q37688363) (← links)
- Developmental trajectories, critical windows and phenotypic alteration during cardio-respiratory development (Q37877313) (← links)
- Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension (Q38099709) (← links)
- The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models (Q38102555) (← links)
- Stem cells of the adult lung: their development and role in homeostasis, regeneration, and disease (Q38116936) (← links)
- Development and pathologies of the arterial wall (Q38144750) (← links)
- Neuron-derived orphan receptor 1 promoted human pulmonary artery smooth muscle cells proliferation (Q38299957) (← links)
- A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension (Q39159352) (← links)
- Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway (Q40420885) (← links)
- Transient Receptor Potential Channel 4 Encodes a Vascular Permeability Defect and High-Frequency Ca(2 ) Transients in Severe Pulmonary Arterial Hypertension (Q41841126) (← links)
- Cigarette smoke extract stimulates rat pulmonary artery smooth muscle cell proliferation via PKC-PDGFB signaling (Q41952153) (← links)
- Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change (Q42145272) (← links)
- Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition (Q45352755) (← links)
- Reactive Oxygen Species in COPD-Related Vascular Remodeling (Q46280803) (← links)
- Possible role of increased oxidative stress in pulmonary hypertension in experimental diaphragmatic hernia (Q46644212) (← links)
- Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat. (Q47434568) (← links)
- Stress Analysis-Driven Design of Bilayered Scaffolds for Tissue-Engineered Vascular Grafts (Q47698272) (← links)
- Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats (Q47966441) (← links)
- MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1). (Q48045287) (← links)
- Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension. (Q48313046) (← links)
- Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension (Q48533276) (← links)
- Characteristics of Pulmonary Vascular Remodeling in a Novel Model of Shunt-Associated Pulmonary Arterial Hypertension (Q51733063) (← links)
- Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells. (Q52668742) (← links)
- Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension. (Q52892107) (← links)
- Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats. (Q53116849) (← links)
- Targeted gene delivery ofBMPR2attenuates pulmonary hypertension (Q54575864) (← links)
- Role of Krüppel-like factor 4 in cigarette smoke-induced pulmonary vascular remodeling. (Q55077620) (← links)
- Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension (Q60923995) (← links)
- Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension (Q84975415) (← links)
- New Diagnostic and Therapeutic Strategies for Pulmonary Hypertension Associated with Left Heart Disease (Q87288289) (← links)